Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Diabetes Res Clin Pract. 2022 Jun;188:109912. doi: 10.1016/j.diabres.2022.109912. Epub 2022 May 10.
We aimed to report the burden of type 1 diabetes mellitus (T1DM) in the North Africa and Middle East region and its 21 countries from 1990 to 2019.
Information related to incidence, prevalence, mortality, disability-adjusted life-years (DALYs), and years lived with disability (YLDs) of T1DM was acquired from the 2019 Global Burden of Disease study. The burden was estimated by sex, age groups, and socio-demographic index (SDI) in 21 countries.
Over the past 30 years, regional incidence, prevalence, mortality, and DALYs of T1DM increase by 188.7%, 304.8%, 43.7%, and 71.6%, respectively. While the age-standardized incidence and prevalence rates increased by 84% and 91%, the mortality and DALYs rates decreased by 34% and 13%. During these years, the contribution of YLDs to total DALYs increased considerably (from 17% to 42%). The highest increase in the incidence and prevalence rates occurred in high SDI countries. Moreover, the Mortality to Incidence Ratio (MIR) decreased in the region countries.
Despite progress made in diabetes care, there is a persistently increasing burden of T1DM in the region countries. This indicates that T1DM is still one of the major health challenges in the region countries, especially in high SDI Arab countries.
本研究旨在报告 1990 年至 2019 年期间北非和中东地区 21 个国家的 1 型糖尿病(T1DM)负担情况。
从 2019 年全球疾病负担研究中获取 T1DM 的发病率、患病率、死亡率、伤残调整生命年(DALYs)和伤残所致寿命损失年(YLDs)相关信息。在 21 个国家中,按性别、年龄组和社会人口指数(SDI)来评估负担。
在过去 30 年中,T1DM 的区域发病率、患病率、死亡率和 DALYs 分别增长了 188.7%、304.8%、43.7%和 71.6%。尽管年龄标准化发病率和患病率分别增长了 84%和 91%,但死亡率和 DALYs 分别下降了 34%和 13%。在此期间,YLDs 对总 DALYs 的贡献显著增加(从 17%增至 42%)。高 SDI 国家的发病率和患病率增长率最高。此外,该地区国家的死亡率与发病率比值(MIR)有所下降。
尽管在糖尿病治疗方面取得了进展,但该地区国家的 T1DM 负担仍在持续增加。这表明 T1DM 仍是该地区国家面临的主要健康挑战之一,尤其是在高 SDI 的阿拉伯国家。